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A B S T R A C T
We analyzed the influence of cytology development to frequency of precancerosa (Cer-
vical intraepithelial neoplasia grade 3 – CIN 3) and cervical cancer. The number of ex-
amined Pap smears increased significantly in the analyzed period. The calculated linear
trend shows an average four-year increase of 17,283.35 smears. The number of detected
CIN 3 increased accordingly. The calculated linear trend shows an average four-year
increase by 45.03 and decrease of the rate of 0.07. A slight increase in cervical cancer
was also noticed. The calculated linear trend shows an average four-year increase in
cancer by 1.6 and decrease in the rate of 0.51. Analyses of cervical cancer by stages
showed an increase in number of stage I and decrease of other stages. The calculated
linear trend shows an average four-year increase of stage I by 4.94 or decrease in other
stages of cervical cancer of 3.29 respectively. The rate of cervical cancer stage I decreased
by 0.11 and of other stages by 0.39. Further analyses of the stage I showed that the lin-
ear trend of IA stage had an average four-year increase by 5.40 and decrease in stage IB
of 0.48. The rate of the cervical cancer stage IA increased by 0.02, whereas the rate of IB
decreased by 0.13. Cytology development in our country has resulted in detection of
higher number of CIN 3 and the earliest stage (IA) of cervical cancer whereas the num-
ber of other stages (IB, II, III, IV) has decreased. However, a total number of cervical can-
cers haven’t changed over the whole period. Thus, it is obvious that opportunistic pro-
gram of detection, which has been using in Croatia, could not decrease frequency of
cervical cancer. In order to achieve it, well-organized national program of detection is
needed.
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Introduction
Cytological smear is a method of choi-
ce in detection of precancerosa and early
stages of cervical cancer because those le-
sions are easy to localize, they develop
rather slowly and have very well defined
phases of development1–5.
Pap smear cannot detect only very
rare, rapidly progressive cervical cancers,
which do not have the above phases of de-
velopment but directly grow into stroma,
in their early stage6,7. The bad thing is
that those cancers are more frequent in
women younger than 40. Fortunately, there
are only 10.0% of those cancers8,9.
Screening for cancer of the cervix with
cervicovaginal smear had been introdu-
ced in the United States and developed
West European countries more than 30
years ago5,10,11. Just with implementation
of the organized national program of de-
tection, which included all women in risk
age (older than 30 years), those countries
succeeded to reduce total number of can-
cer and number of late stages of cancer. It
has been confirmed in many reports of
cervical cancer incidence and mortality
rate12–15.
Most number of developing countries
use opportunistic program of detection of
cervical cancer, which includes only wo-
men who visit their gynecologist no mat-
ter what reason is16,17. As this program of
detection does not include huge amount
of risk population, it couldn’t significant-
ly decrease cervical cancer incidence and
mortality rate18,19.
The aim of this study is to estimate
the influence of cytology development
and opportunistic detection program in
observing period on CIN 3 frequency, cer-
vical cancer frequency, their relationships
and also relation between early and late
stages of cancer.
Material and Methods
The number of examined Pap smears
over four-year periods in the University
Hospital »Osijek« (1978–2001) was ana-
lyzed. Trends in the number of detected
precancerosa and cancers of the uterine
cervix were analyzed as well and their re-
lationship and relation between early and
advanced stages.
Pap smear as method of secondary
prevention of cancer of the uterine cervix
was introduced in the University Hospi-
tal »Osijek« in 1965. Providing that a
woman comes for gynecologic check-up
once a year she has her smear examined,
and in case of any abnormality Pap smear
is examined even more frequent -as rec-
ommended by the cytologist. Pap smear
is taken from the back fornix of the va-
gina, from the cervix surface and from the
cervical canal – and is placed on a slide.
University Hospital »Osijek« takes care
of almost all patients from Osje~ko-ba-
ranjska and Vukovarsko-srijemska coun-
ties. On this area live, according to the
last census from 2001, 278,127 women. In
these two counties there are still three
smaller hospitals, but almost all women
with cervical cancer have been treated in
University Hospital Osijek.
In relation to the rate using Pap smears
in detection of precancerosa and cervical
cancer, the analyzed period can be di-
vided into three sub periods. In the first
sub period 1965–1974, there was only one
gynecologist who had completed a course
in cytodiagnostics and, besides his regu-
lar job at the Department of Gynecology
and Obstetrics, he engaged in cytology as
well. There was also one cytoscreener and
one technician working in the cytological
laboratory of the Gynecologic Department.
In that sub period Pap smear had been
taken sporadically (3,406 smears per year
on the average). In the second sub period
1975–1983, the laboratory employed doc-
tors who were specializing medical cytol-
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ogy as their primary and only occupation.
They also taught young colleagues – cy-
toscreeners and established Department
of Cytology as a part of the Department of
Gynecology. Over this sub period Pap smear
was taken more frequently but still not
every patient who had come for gyne-
cologic check-up was taken Pap smear
(7,508 smears per year on the average) In
the last sub period 1984–2001, altogether
5 specialists in cytology were employed as
well as 5 cytoscreeners and 3 technicians.
They all worked at the independent De-
partment of Clinical Cytology. All women
coming for gynecologic check-up had Pap
smear (25,691 smears per year on the av-
erage). It included women who had some
gynecological disorders, pregnant women
and healthy women who were coming once
a year on regular gynecological check-up.
According to the above data it is no-
ticeable that as a consequence of cytology
development and doctors’ and patients’
awareness of the importance of cytology
as method of secondary prevention of cer-
vical cancer, the number of Pap smears
increased in the analyzed period by 7.5x.
But, in spite of cytology development, op-
portunistic program of cervical cancer de-
tection further is continuing, because or-
ganized national program of detection
does not exist.
In our analyses we used medical docu-
mentation of the Department of Gynecol-
ogy and Obstetrics and the Department
of Clinical Cytology of the University
Hospital »Osijek«.
For statistical analyses we used: linear
trend equation, linear regression equa-
tion, Pearson’s correlation coefficient,
Spearman’s rank coefficient. The rate for
all kinds of lesions in relation to the num-
ber of cytological smears over analyzed
periods was also calculated.
Results
Over the period 1978–2001 (24 years),
412,825 cytological smears were exam-
ined and 1,772 CIN 3 and 760 cervical
cancers detected.
Table 1 shows that CIN 3 is the most
frequent in women aged from 30 to 50
years, and very rare in age over 50 years.
Opposite, cervical cancer is most frequent
in women over 50 years, and very rare in
women age under 30 years. Cervical can-
cer was detected in 28 (3.7%) women who
submitted cytology detection regularly
once a year. Other women have not been
submitted to cytology detection.
Figure 1 shows, according to their dis-
tribution over the years, that the curve of
CIN 3 follows the curve of the examined
smears. It also shows that the curve of
the number of smears has no influence on
the curve of cervical cancers.
In order to get more accurate data we
analyzed the number of examined smears,
CIN 3 and cervical cancers over four-year
periods.
According to the calculated linear trend
equation, there is an average four-year
increase in the number of examined
smears by 17283.35 (yc = 41910.8095 
17283.3492x) (Figure 2).
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TABLE 1
DISTRIBUTION OF PRECANCEROSA AND CERVICAL CANCER ACCORDING TO AGE







CIN 3 475 32.7 875 60.2 103 7.1 1,453 100.0
Cervical cancer 11 2.2 194 39.0 293 58.8 760 100.0
The calculated linear trend equation
shows that there is an average four-year
increase in the number of cervical can-
cers by 45.0 as well (yc = 174.4286 
45.0286x). At the same time, an average
four-year trend in the rate decrease of
0.07 (yc=3.3.459-0.0749x) was noted. The
difference is statistically significant (2=
129.12, 20.05=11.07) (Figure 2).
The calculated linear trend equation
shows that there is also an average four-
year increase in the number of cervical
cancers by 1.66. (yc = 122.5238  1.6571x).
At the same time, an average four-year
trend in the rate decrease of 0.51 (yc =
3.1237 – 0.5085x) was noted. The differ-




The calculated linear regression equa-
tion shows that increase in the number of
women with CIN 3 by one will result in
an average increase in the number of
women with cervical cancer by 0.05 wo-
men (y = 112.7718  0.0484x). With 95%
confidence intervals it could be said that
the regression coefficient (b) is higher
than –0.132, and lower than 0.229. Pear-
son’s correlation coefficient shows a weak
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Fig. 1. Distribution of cytological smers, cervical cancers and CIN 3 in the analyzed period.
Fig. 2. Linear trend of the average number of patients with CIN 3 and cervical cancers
in 4-years period.
positive correlation between the number
of women with CIN3 and those with cer-
vical cancer (r=0.349) but it is not statis-
tically significant. (t=0.7449, t0.05(4)=
2.7765, p=0.4977). Spearman’s rank coef-
ficient also shows that there is a weak
positive correlation (rs=0.2) between the
number of women with CIN 3 and those
with cervical cancer. It isn’t statistically
significant as well (rs=0.2, rs0.05= 0.8286).
Distribution of the number of women
with early (I) stage and advanced (II, III,
IV) stages of cervical cancer over four-
year periods was analyzed separately.
The calculated linear trend equation
shows an average four-year increase in
the number of cancers in early stage by
4.49 or decrease in advanced stages of
3.29 respectively (yc = 37.4762  4.9429x,
yc = 85.0476 – 3.2857x). At the same time,
an average four-year trend in rate de-
crease of early stage by 0.11 was noted.
(yc = 0.9462 – 0.1141x) whereas the rate
of advanced stages decreased by 0.39 (yc =
2.1777 – 0.3954x). The difference is sta-
tistically significant. (2=29.33 or 2=
181.61, 20.05=11.07 respectively) (Table 2).
Moreover, we had divided stage I into
IA and IB and analyzed separately their
distribution over four-year periods. Ac-
cording to the calculated linear trend
equation there is an average four-year in-
crease in the number of cancers stage IA
by 5.40 and decrease in IB of 0.48 (yc =
7.0000  5.3999x, or yc = 30.4762 – 04571x
respectively). At the same time we noted
an increase in the rate of IA by 0.02 and
decrease in IB of 0.13 (yc = 0.1821 
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TABLE 2
DISTRIBUTION OF NUMBER AND RATE OF CERVICAL CANCER STAGE I AND
OTHER STAGES OVER FOUR-YEAR PERIODS
Period
Pap smear CIN 3 Cervical cancer
Number Number Rate Number Rate
1978–1981 29825 93 3.118 115 3.856
1982–1985 56979 159 2.791 146 2.562
1986–1989 108768 556 5.112 132 1.214
1990–1993 86962 246 2.829 109 1.253
1994–1997 97060 256 2.638 98 1.010
1998–2001 131121 412 3.142 160 1.220
TABLE 3
DISTRIBUTION OF NUMBER AND RATE OF CERVICAL CANCER STAGES IA
AND IB OVER FOUR-YEAR PERIODS
Periods
Pap smear Cervical cancer stage IA Cervical cancer stage IB
Number Number Rate Number Rate
1978–1981 29,825 4 0.134 28 0.939
1982–1985 56,979 16 0.281 36 0.632
1986–1989 108,768 24 0.221 34 0.313
1990–1993 86,962 18 0.207 19 0.218
1994–1997 97,060 21 0.216 24 0.247
1998–2001 131,121 40 0.305 35 0.267
0.0185x or yc = 0.7653 – 0.1317x). The dif-
ference for IA is not statistically signifi-
cant but it is significant for IB. (2=4.87 or

2=53.50, 20.05=11.07 respectively) (Table 3).
Discussion
Owing to cytology development and
successfully organized screening pro-
grams the advanced industrialized coun-
tries have lower incidence and mortality
of cervical cancer20–22.
Cytology development as an almost
ideal method of screening for cervical
cancer has been moving up in our country
as well. Former cytological laboratory
with only one gynecologist, who comple-
ted a course in cytology and spent only
part of his working hours in the labora-
tory, has developed into a Department of
Clinical Cytology, which employs five cy-
tologists, two of whom practice gyneco-
logic cytology and the others according to
circumstances. Besides, there are five cy-
toscreeners in the laboratory as well.
The above development resulted in
growing number of examined Pap smears
in the observed period i.e. more women
were involved in the screening program.
The increased number of examined
Pap smears resulted in higher number of
detected CIN 323,24. At the same time
however, statistically significant decrea-
se in CIN 3 rate was noted in relation to
the number of cytological examinations.
The curves of the Figure showing distri-
bution of the number of examined smears
and the number of CIN 3 over the ob-
served period are almost identical. Tran-
sitory considerable decrease in the num-
ber of examined smears and detected CIN
3 as well as a slight decrease in cervical
cancer in the period 1990–1997 is more
likely a consequence of political changes
and war in the region that influenced mi-
gration, especially of female population.
On the other hand, women who hadn’t
left the war-affected region didn’t think of
prevention as being the priority at that
time.
Positive influence of cytology develop-
ment to increase in the number of de-
tected precancerosa doesn’t influence a
gradual decrease in occurrence of inva-
sive cervical cancer – what is to be ex-
pected. Moreover, in the observed period
we even noted a slight increase in the
number of women with cervical cancer.
On the other hand, the rate of cervical
cancer in relation to the number of exam-
ined smears was significantly lower.
According to reference literature it’s
the same in the whole country. There are
no data on decrease in incidence of cervi-
cal cancer and mortality25.
As we already mentioned, there were
migrations in the region due to war in the
period 1990–1997. Because of that all da-
ta from that period are not to be taken for
granted. The number of examined smears
decreased slightly in those four-year peri-
ods (1990–1993 and 1994–1997) in rela-
tion to the previous one (1986–1989).
However, the number of CIN 3 in those
four-year periods was halved in relation
to the previous one but still it was signifi-
cantly larger than in the first two ana-
lyzed four-year periods (1978–1981 and
1982–1985) when cytology hadn’t been
developed well enough. The number of
women with cervical cancer decreased in
those periods as well. After most of the
women who had left the region returned
(1998–2001) the number of examined
smears and cervical cancers increased
but the number of detected CIN 3 was al-
most the same as before the war? In spite
of very bad working conditions for sec-
ondary prevention of cervical cancer dur-
ing the war, there was no significant in-
crease in advanced stages of cancer
afterwards. It is very likely a consequen-
ce of detection of precancerosa and early
stages of cancer before the war. An inten-
sive work on secondary prevention in the
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last period resulted again in detection of
the earliest stages.
In conclusion, it could be said that cy-
tology development in our country resul-
ted in detection of large numbers of wo-
men with CIN 3 and the earliest stage of
cervical cancer IA whereas the number of
women with other stages (IB, II, III, IV)
declined. On the other hand, a total num-
ber of women with cervical cancer re-
mained steady over the whole period. It
means that opportunistic program of de-
tection, which has been using in Croatia,
could not decrease the incidence of cervi-
cal cancer. It just maintains the present
state. It is obvious that using this pro-
gram of detection we did not succeed to
enough reduce the number of women out
of detection program.
That part of population that has not
been included in screening program yet
could be lessening by an intensive cam-
paign in secondary schools and through
media (better primary prevention). How-
ever, it is proved that significant decrease
in incidence and mortality rate of cervical
cancer could be achieved by well-orga-
nized national program of detection.
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UTJECAJ RAZVOJA CITOLOGIJE NA U^ESTALOST PREKANCEROZA
I RAKA CERVIKSA U KLINI^KOJ BOLNICI OSIJEK, U RAZDOBLJU
OD 1978 DO 2001 GODINE
S A @ E T A K
Analizirali smo utjecaj razvoja citologije na u~estalost prekanceroza (cervikalna in-
traepitelna neoplazija 3. stupnja – CIN 3) i raka cerviksa. Broj pregleda citolo{kog
obriska cerviksa uterusa zna~ajno je porastao u analiziranom razdoblju. Izra~unati li-
nearni trend pokazuje prosje~ni ~etverogodi{nji rast od 17283.35 citolo{ka obriska.
Sukladno tomu porastao je i broj otkrivenih CIN 3. Izra~unati linearni trend pokazuje
prosje~ni ~etverogodi{nji porast CIN 3 za 45,03 i pad stope za 0,07. Tako|er je primi-
je}en i blagi porast raka cerviksa. Izra~unati linearni trend pokazuje prosje~ni ~etve-
rogodi{nji porast raka za 1.6 i pad stope za 0,51. Analizom raka cerviksa po stadijima
utvr|en je porast broja raka I stadija i pad broja ostalih stadija. Izra~unati linearni
trend pokazuje prosje~ni ~etverogodi{nji porast raka I stadija za 4,94 odnosno pad
ostalih stadija raka cerviksa za 3,29. Stopa raka cerviksa I stadija pala je za 0,11 a
ostalih stadija za 0,39. Daljom analizom I stadija izra~unati linearni trend za IA stadij
pokazuje prosje~ni ~etverogodi{nji porast za 5,40 i pad stadija IB za 0,48. Stopa raka
cerviksa IA stadija porasla je za 0,02 a stopa IB je pala za 0,13. Zaklju~ak. Razvoj
citologije u nas je imao za posljedicu otkrivanje ve}eg broja CIN 3 i najranijeg stadija
(IA) raka cerviksa dok se broj ostalih stadija (IB, II, III, IV) raka smanjio. Ukupan broj
karcinoma cerviksa ostao je, me|utim, isti kroz ~itavo razdoblje. Tako, oportunisti~ki
program probira koji se u nas primjenjuje, ne mo`e smanjiti u~estalost raka vrata ma-
ternice. Da bi se to postiglo potrebno je stvoriti dobar organizirani nacionalni program
probira.
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